Suarez, Catherine L.

HRN: 23-90-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2023
CEFUROXIME 1.5GM (VIAL)
10/30/2023
10/30/2023
IVT
1.5g
On Call To OR ANST
AUB Rule Out Endometrial Pathology; Bilateral ONG; Hypertension Stage II; G2P1 (1010)
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: